Načítá se...
Hepatocellular carcinoma, novel therapies on the horizon
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is associated with high mortality rate. Incidence remains high due to the persistent prevalence of viral hepatitis, alcoholic cirrhosis, and non-alcoholic fatty liver disease (NFLD). Despite screening efforts, the majority of...
Uloženo v:
| Vydáno v: | Chin Clin Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8279038/ https://ncbi.nlm.nih.gov/pubmed/32527116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cco-20-113 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|